Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Long-Term Investments: 2022-2023

Historic Long-Term Investments for OptimizeRx (OPRX) over the last 2 years, with FY2023 value amounting to $568000.0.

  • OptimizeRx's Long-Term Investments changed N/A to $434000.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $434000.0, marking a year-over-year change of. This contributed to the annual value of $568000.0 for FY2023, which is 9898.39% down from last year.
  • OptimizeRx's Long-Term Investments amounted to $568000.0 in FY2023, which was down 9898.39% from $55.9 million recorded in FY2022.
  • Over the past 5 years, OptimizeRx's Long-Term Investments peaked at $55.9 million during FY2022, and registered a low of $568000.0 during FY2023.